silver has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casey, AL; Cook, M; Elliott, TS; Karpanen, TJ; Nightingale, P | 1 |
| Batarseh, KI | 1 |
1 trial(s) available for silver and Hematologic Malignancies
| Article | Year |
|---|---|
Microbiological comparison of a silver-coated and a non-coated needleless intravascular connector in clinical use.
Topics: Adult; Aged; Bacteria; Catheter-Related Infections; Catheters, Indwelling; Coated Materials, Biocompatible; Colony Count, Microbial; Disinfectants; Female; Fungi; Hematologic Neoplasms; Humans; Male; Middle Aged; Silver; Young Adult | 2012 |
1 other study(ies) available for silver and Hematologic Malignancies
| Article | Year |
|---|---|
A novel silver (I) chelate: cytotoxicity and apoptotic mechanism of action on human hematopoietic malignancies.
Topics: Apoptosis; Cell Line, Tumor; Chelating Agents; Hematologic Neoplasms; Humans; Silver | 2008 |